Rights and permissions
About this article
Cite this article
Delayed treatment affects QOL but not costs in OSAS. Pharmacoecon. Outcomes News 447, 14 (2004). https://doi.org/10.2165/00151234-200404470-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404470-00033